APOE ε4 and the Influence of Sex, Age, Vascular Risk Factors, and Ethnicity on Cognitive Decline.
Level 3 - non-randomized controlled study
Individual participant data meta-analysis of longitudinal observational cohort studies
PubMed 32396611 · doi:10.1093/gerona/glaa116
What was done
Researchers conducted a two-step individual participant data meta-analysis of 19,225 individuals (aged 54–103 years) from 15 longitudinal cohort studies with mean follow-up durations between 1.2 and 10.7 years. They examined the relationship between APOE ε4 (APOE*4) carriage (one or two alleles) and decline in memory and general cognition, testing moderation by sex, baseline age (evaluated at approximately 62 versus 80 years), vascular risk factors, and ethnicity.
What was found
The abstract reports directional findings without numerical values, confidence intervals, or test statistics. APOE*4 carriage was associated with faster general cognitive decline in women and faster memory decline in men. Older men showed a dose-dependent effect, with faster general cognitive and memory decline in those carrying two alleles versus one. Vascular risk factors increased the effect of APOE*4 on memory decline in younger women, but weakened its effect on general cognitive decline in older men. The relationship between APOE*4 carriage and memory decline was stronger in older Asians than in Whites.
Why it matters
The findings show that APOE*4 genetic risk for cognitive decline does not act uniformly, but is modulated by demographic, vascular, and ethnic factors.
Limits
The abstract provides no effect sizes, standard errors, or p-values. As an observational meta-analysis, causality cannot be definitively established, and follow-up duration varied widely across the included cohorts (1.2 to 10.7 years).
Cited by
- supports The APOE4 genetic marker is associated with cognitive decline.